Ovid Therapeutics Net Debt Growth & History (OVID)

Ovid Therapeutics's net debt was $266,000 for fiscal 2025.

View full Ovid Therapeutics company overview

Ovid Therapeutics annual net debt history

Ovid Therapeutics annual net debt

Fiscal yearPeriod endedNet debtChangeGrowth
20252025-12-31$266,000$11.8M
20242024-12-31−$11.5M−$506,000
20232023-12-31−$11.0M$17.3M
20222022-12-31−$28.3M$159.5M
20212021-12-31−$187.8M

Ovid Therapeutics net debt trends

Between the periods ended 2021-12-31 and 2025-12-31, Ovid Therapeutics's net debt increased from −$187.8M to $266,000, a change of $188.1M. The latest reported quarter, Q2 2026, shows $1.4M.

About the metric

What net debt means

Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.

Calculation and source

How net debt is calculated

TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Ovid Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about OVID yet. Start the conversation.

Write the first post